FdaApplication
NDA 212725
Identifiers
- fda_app_no: NDA212725
Properties
| Property | Value |
|---|---|
| applicant_name | GENENTECH INC |
| application_type | NDA |
| approval_date | 2019-08-15 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ROZLYTREK | ENTRECTINIB | 100MG | CAPSULE;ORAL |
| ROZLYTREK | ENTRECTINIB | 200MG | CAPSULE;ORAL |
2 products